{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:56:32Z","timestamp":1781567792289,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early identification of pregnancies at risk for gestational hypertension (gHTN) and preeclampsia (PE) remains a major clinical challenge. We investigated whether early\u2011pregnancy serum metabolomic profiles differentiate gHTN and PE prior to clinical onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      High-resolution metabolomics (HRM) analysis was performed on 126 early-pregnancy serum samples collected at\u2009\u2264\u200920\u00a0weeks\u2019 gestation from 97 pregnant women enrolled in the Placental Assessment in Response to Environmental Pollution study (PARENTs) cohort at UCLA. Metabolic profiles were compared among pregnancies that later developed gestational hypertension (gHTN;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914 mothers, 20 samples), preeclampsia (PE;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099 mothers, 11 samples), and pregnancies without ischemic placental disease (non-IPD;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200974 mothers, 95 samples). Untargeted metabolome-wide association studies (MWAS) and pathway enrichment analyses were conducted. Multivariable linear regression models adjusted for key maternal and pregnancy characteristics such as maternal age, race\/ethnicity, early-pregnancy BMI, fetal sex, and parity were used to evaluate associations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Distinct metabolic profiles differentiated gHTN and PE from non-IPD pregnancies. Alterations in the tryptophan metabolism pathway were observed in both gHTN and PE, with a significant dose\u2013response relationship across groups (non-IPD\u2009&gt;\u2009gHTN\u2009&gt;\u2009PE,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). Key metabolites, including tryptophan and its derivatives, were progressively depleted in association with increasing disease severity. Additionally, urea cycle metabolism was altered in gHTN, with higher levels of arginine and citrulline linked to nitric oxide production and vascular tone regulation. Comparisons between PE and gHTN revealed additional differences, including lower concentration of phenylalanine and pantothenic acid in PE, suggesting distinct metabolic alteration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early\u2011pregnancy metabolomic signatures reveal both shared and condition\u2011specific metabolic pathways underlying gHTN and PE, with tryptophan metabolism showing a dose\u2013response relationship indicative of disease severity. These early gestational alterations may serve as biomarkers for hypertensive disorders of pregnancy (HDP), enabling closer monitoring and stratification in high-risk pregnancies. Further studies in larger cohorts are needed to validate these findings and explore therapeutic implications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09168-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:16:43Z","timestamp":1777432603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum metabolomics in early pregnancy differentiates between gestational hypertension and preeclampsia"],"prefix":"10.1186","volume":"26","author":[{"given":"Tahmineh R.","family":"Kalbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Janzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Nellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin U.","family":"Devaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"9168_CR1","doi-asserted-by":"crossref","unstructured":"Center for Disease Control and Prevention. Hypertensive disorders in pregnancy and mortality at delivery hospitalization \u2014 United States, 2017\u20132019 | MMWR. MMWR. Morbidity and mortality weekly report. 2022. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7117a1.htm.","DOI":"10.15585\/mmwr.mm7117a1"},{"key":"9168_CR2","doi-asserted-by":"crossref","unstructured":"Radparvar AA, Vani K, Fiori K, Gupta S, Chavez P, Fisher M, et al. Innovative management strategies. JACC Adv. 2024;3(3). Available from: https:\/\/www.jacc.org\/doi\/10.1016\/j.jacadv.2024.100864.","DOI":"10.1016\/j.jacadv.2024.100864"},{"key":"9168_CR3","doi-asserted-by":"crossref","unstructured":"Khan KS, Wojdyla D, Say L, G\u00fclmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet (London, England). 2006;367(9516). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16581405.","DOI":"10.1016\/S0140-6736(06)68397-9"},{"key":"9168_CR4","doi-asserted-by":"crossref","unstructured":"Mayrink J, Leite DF, Nobrega GM, Costa ML, Cecatti JG. Prediction of pregnancy-related hypertensive disorders using metabolomics: a systematic review. BMJ Open. 2022;12(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35470187\/. Cited 2025 Dec 10.","DOI":"10.1136\/bmjopen-2021-054697"},{"key":"9168_CR5","doi-asserted-by":"crossref","unstructured":"Ferranti E, Frediani J, Mitchell R, Fernandes J, Li S, Jones D, et al. Early pregnancy serum metabolite profiles associated with hypertensive disorders of pregnancy in african american women: a pilot study. J Pregnancy. 2020;2020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32148965.","DOI":"10.1155\/2020\/1515321"},{"key":"9168_CR6","doi-asserted-by":"crossref","unstructured":"Marie A, Line TH, Ragnhild SB, Kjell S, Rigmor A, Ann-Charlotte I, et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int J Mol Sci. 2015;16(9). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26370975.","DOI":"10.3390\/ijms160921520"},{"key":"9168_CR7","doi-asserted-by":"crossref","unstructured":"Uppal K, Walker ID, Liu K, Li S, Go YM, Jones PD. Computational metabolomics: a framework for the million metabolome. Chem Res Toxicol. 2016;29(12). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27629808.","DOI":"10.1021\/acs.chemrestox.6b00179"},{"key":"9168_CR8","doi-asserted-by":"crossref","unstructured":"Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, et al. Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern neonatal Med. 2012;25(10). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22494326.","DOI":"10.3109\/14767058.2012.680254"},{"key":"9168_CR9","doi-asserted-by":"crossref","unstructured":"Harville EW, Li YY, Pan K, McRitchie S, Pathmasiri W, Sumner S. Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study. Sci Rep. 2021;11(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33568690.","DOI":"10.1038\/s41598-021-82804-1"},{"key":"9168_CR10","doi-asserted-by":"crossref","unstructured":"Mayrink J, Leite DF, Nobrega GM, Costa ML, Cecatti JG. Prediction of pregnancy-related hypertensive disorders using metabolomics: a systematic review. 2022; Available from: https:\/\/bmjopen.bmj.com\/content\/12\/4\/e054697.abstract.","DOI":"10.1136\/bmjopen-2021-054697"},{"key":"9168_CR11","doi-asserted-by":"crossref","unstructured":"Dasgupta S, Subramani E, Mitra I, Bhattacharya A, Sherpa DD, Joshi M, et al. Discovery of novel metabolic signatures for early identification of women at risk of developing gestational hypertension. Metabolomics. 2023;19(5). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37154845.","DOI":"10.1007\/s11306-023-02012-y"},{"key":"9168_CR12","doi-asserted-by":"crossref","unstructured":"Janzen C, Lei YYM, Lee B, Vangala S, DelRosario I, Meng Q, et al. A description of the imaging innovations for placental assessment in response to environmental pollution study. Am J Perinatol. 2022; Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36241211.","DOI":"10.1055\/a-1961-2059"},{"key":"9168_CR13","doi-asserted-by":"crossref","unstructured":"Nachman RM, Mao G, Zhang X, Hong X, Chen Z, Soria CS, et al. Intrauterine inflammation and maternal exposure to ambient PM2.5 during preconception and specific periods of pregnancy: the boston birth cohort. Environ Health Perspect. 2016;124(10). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27120296.","DOI":"10.1289\/EHP243"},{"key":"9168_CR14","doi-asserted-by":"crossref","unstructured":"Ananth C V. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol. 2014;38(3). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24836823.","DOI":"10.1053\/j.semperi.2014.03.001"},{"key":"9168_CR15","doi-asserted-by":"crossref","unstructured":"Ananth VC, Vintzileos MA. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17014813.","DOI":"10.1016\/j.ajog.2006.05.021"},{"key":"9168_CR16","doi-asserted-by":"crossref","unstructured":"Liu KH, Lee CM, Singer G, Bais P, Castellanos F, Woodworth MH, et al. Large scale enzyme based xenobiotic identification for exposomics. Nat Commun. 2021;12(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34521839.","DOI":"10.1038\/s41467-021-25698-x"},{"key":"9168_CR17","doi-asserted-by":"crossref","unstructured":"Uppal K, Soltow QA, Strobel FH, Pittard WS, Gernert KM, Yu T, et al. XMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics. 2013;14(1):1\u201312. Available from: https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-14-15. Cited 2022 May 8.","DOI":"10.1186\/1471-2105-14-15"},{"key":"9168_CR18","doi-asserted-by":"crossref","unstructured":"Yu T, Park Y, Li S, Jones DP. Hybrid feature detection and information accumulation using high-resolution LC- MS metabolomics data. J Proteome Res. 2013;12(3):1419\u201327. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624888\/pdf\/nihms445571.pdf.","DOI":"10.1021\/pr301053d"},{"key":"9168_CR19","doi-asserted-by":"crossref","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16632515.","DOI":"10.1093\/biostatistics\/kxj037"},{"key":"9168_CR20","doi-asserted-by":"crossref","unstructured":"Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6(6). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21637195.","DOI":"10.1038\/nprot.2011.319"},{"key":"9168_CR21","doi-asserted-by":"crossref","unstructured":"Bolstad BM, Irizarry RA, Magnus \u00c5, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12538238.","DOI":"10.1093\/bioinformatics\/19.2.185"},{"key":"9168_CR22","doi-asserted-by":"crossref","unstructured":"Kohl SM, Klein MS, Hochrein J, Oefner PJ, Spang R, Gronwald W. State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics. 2012;8(Suppl 1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22593726.","DOI":"10.1007\/s11306-011-0350-z"},{"key":"9168_CR23","doi-asserted-by":"crossref","unstructured":"Pounds S, Cheng C. Robust estimation of the false discovery rate. Bioinformatics. 2006;22(16). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16777905.","DOI":"10.1093\/bioinformatics\/btl328"},{"key":"9168_CR24","doi-asserted-by":"crossref","unstructured":"Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, et al. Predicting network activity from high throughput metabolomics. PLoS Comput Biol. 2013;9(7):e1003123. Available from: https:\/\/journals.plos.org\/ploscompbiol\/article\/file?id=10.1371\/journal.pcbi.1003123&type=printable.","DOI":"10.1371\/journal.pcbi.1003123"},{"key":"9168_CR25","doi-asserted-by":"crossref","unstructured":"Magee AL, Wright D, Syngelaki A, Dadelszen P von, Akolekar R, Wright A, et al. Preeclampsia prevention by timed birth at term. Hypertension. 2023;80(5). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37035913.","DOI":"10.1161\/HYPERTENSIONAHA.122.20565"},{"key":"9168_CR26","doi-asserted-by":"crossref","unstructured":"Wu G, Morris JS. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336 ( Pt 1(Pt 1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9806879.","DOI":"10.1042\/bj3360001"},{"key":"9168_CR27","doi-asserted-by":"crossref","unstructured":"Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1852778.","DOI":"10.1016\/S0031-6997(25)06663-3"},{"key":"9168_CR28","doi-asserted-by":"crossref","unstructured":"Breuillard C, Cynober L, Moinard C. Citrulline and nitrogen homeostasis: an overview. Amino Acids. 2015;47(4). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25676932.","DOI":"10.1007\/s00726-015-1932-2"},{"key":"9168_CR29","doi-asserted-by":"crossref","unstructured":"Morris JS. Enzymes of arginine metabolism. J Nutr. 2004;134(10 Suppl). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15465778.","DOI":"10.1093\/jn\/134.10.2743S"},{"key":"9168_CR30","doi-asserted-by":"crossref","unstructured":"Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22112350.","DOI":"10.2174\/157016112798829760"},{"key":"9168_CR31","doi-asserted-by":"crossref","unstructured":"Ambrosino P, Grassi G, Maniscalco M. Endothelial dysfunction: from a pathophysiological mechanism to a potential therapeutic target. Biomedicines. 2021;10(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35052760.","DOI":"10.3390\/biomedicines10010078"},{"key":"9168_CR32","doi-asserted-by":"crossref","unstructured":"Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol. 2001;38 Suppl 2. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11811368.","DOI":"10.1097\/00005344-200111002-00004"},{"key":"9168_CR33","doi-asserted-by":"crossref","unstructured":"Khedagi AM, Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin. 2021;39(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33222817.","DOI":"10.1016\/j.ccl.2020.09.005"},{"key":"9168_CR34","doi-asserted-by":"crossref","unstructured":"Gui S, Jia J, Niu X, Bai Y, Zou H, Deng J, et al. Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review. J Renin Angiotensin Aldosterone Syst. 2014;15(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23435582.","DOI":"10.1177\/1470320313475910"},{"key":"9168_CR35","doi-asserted-by":"crossref","unstructured":"Ortiz-Cerda T, Mosso C, Alcudia A, V\u00e1zquez-Rom\u00e1n V, Gonz\u00e1lez-Ortiz M. Pathophysiology of preeclampsia and L-arginine\/L-citrulline supplementation as a potential strategy to improve birth outcomes. Adv Exp Med Biol. 2023;1428. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37466772.","DOI":"10.1007\/978-3-031-32554-0_6"},{"key":"9168_CR36","doi-asserted-by":"crossref","unstructured":"Weckman AM, McDonald CR, Baxter JAB, Fawzi WW, Conroy AL, Kain KC. Perspective: L-arginine and L-citrulline supplementation in pregnancy: a potential strategy to improve birth outcomes in low-resource settings. Adv Nutr. 2019;10(5):765\u201377. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2161831322004239?st_source=ai_mode#cesec30. Cited 2025 Dec 10.","DOI":"10.1093\/advances\/nmz015"},{"key":"9168_CR37","doi-asserted-by":"crossref","unstructured":"Tesfa E, Munshea A, Nibret E, Mekonnen D, Sinishaw MA, Gizaw ST. Maternal serum uric acid, creatinine and blood urea levels in the prediction of pre-eclampsia among pregnant women attending ANC and delivery services at Bahir Dar city public hospitals, northwest Ethiopia: A case-control study. Heliyon. 2022;8(10):e11098. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9593197\/. Cited 2025 Dec 10.","DOI":"10.1016\/j.heliyon.2022.e11098"},{"key":"9168_CR38","doi-asserted-by":"crossref","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2S). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32835720.","DOI":"10.1016\/j.ajog.2020.08.045"},{"key":"9168_CR39","unstructured":"Carney LA, Quinlan JD, West JM. Thyroid disease in pregnancy. Am Fam Physician. 2014;89(4). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24695447."},{"key":"9168_CR40","doi-asserted-by":"crossref","unstructured":"Sedlmayr P, Blaschitz A, Stocker R. The role of placental tryptophan catabolism. Front Immunol. 2014;5. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24904580.","DOI":"10.3389\/fimmu.2014.00230"},{"key":"9168_CR41","doi-asserted-by":"crossref","unstructured":"Keaton SA, Heilman P, Bryleva EY, Madaj Z, Krzyzanowski S, Grit J, et al. Altered tryptophan catabolism in placentas from women with pre-eclampsia. Int J Tryptophan Res. 2019;12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31007529.","DOI":"10.1177\/1178646919840321"},{"key":"9168_CR42","doi-asserted-by":"crossref","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7\u201314. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33418116\/. Cited 2025 Dec 10.","DOI":"10.1016\/j.coi.2020.12.001"},{"key":"9168_CR43","doi-asserted-by":"crossref","unstructured":"Stier Jr. C. Serotonin and dopamine in essential hypertension. Am J Hypertens. 2025;26(2):151. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23382392.","DOI":"10.1093\/ajh\/hps085"},{"key":"9168_CR44","doi-asserted-by":"crossref","unstructured":"Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev. 2012;64(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22407614.","DOI":"10.1124\/pr.111.004697"},{"key":"9168_CR45","doi-asserted-by":"crossref","unstructured":"Zainab JA, Hussein AHK, Samaneh Z, Agata S. Maternal tryptophan catabolites and insulin resistance parameters in preeclampsia. Biomolecules. 2023;13(10). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37892130.","DOI":"10.3390\/biom13101447"},{"key":"9168_CR46","doi-asserted-by":"crossref","unstructured":"Dunn WB, Brown MC, Worton SA, Crocker IP, Broadhurst DI, Horgan RP, et al. Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta. 2009;30(11). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19775752.","DOI":"10.1016\/j.placenta.2009.08.008"},{"key":"9168_CR47","doi-asserted-by":"crossref","unstructured":"Marsden PA. The curious case of tryptophan in pregnancy. J Clin Invest. 2022;132(20). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36250464.","DOI":"10.1172\/JCI164219"},{"key":"9168_CR48","doi-asserted-by":"crossref","unstructured":"Kaihara JNS, de Moraes FR, Nunes PR, Alves MG, Cavalli RC, Tasic L, et al. Plasma metabolic profile reveals signatures of maternal health during gestational hypertension and preeclampsia without and with severe features. PLoS One. 2024;19(11):e0314053. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0314053. Cited 2025 Dec 10.","DOI":"10.1371\/journal.pone.0314053"},{"key":"9168_CR49","doi-asserted-by":"crossref","unstructured":"Han H, Li H, Yuan Q, Zou L, Fang J, Hu N, et al. Exploring metabolic abnormalities of amino acids in preeclampsia-associated cardiac physiological dysfunction via cardiomyocyte-based multimodal biosensing. ACS Nano. 2025;19(38):33828\u201340. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acsnano.5c08157. Cited 2026 Jan 16.","DOI":"10.1021\/acsnano.5c08157"},{"key":"9168_CR50","doi-asserted-by":"crossref","unstructured":"Prameswari N, Irwinda R, Wibowo N, Saroyo YB. Maternal amino acid status in severe preeclampsia: a cross-sectional study. Nutrients. 2022;14(5):1019. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8912593\/. Cited 2026 Jan 16.","DOI":"10.3390\/nu14051019"},{"key":"9168_CR51","doi-asserted-by":"crossref","unstructured":"Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA, Nelson MD, et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn. 2011;31(10). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21744367.","DOI":"10.1002\/pd.2822"},{"key":"9168_CR52","doi-asserted-by":"crossref","unstructured":"Ennis MA, Rasmussen BF, Lim K, Ball RO, Pencharz PB, Courtney-Martin G, et al. Dietary phenylalanine requirements during early and late gestation in healthy pregnant women. Am J Clin Nutr. 2020;111(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31758682.","DOI":"10.1093\/ajcn\/nqz288"},{"key":"9168_CR53","doi-asserted-by":"crossref","unstructured":"Freese R, Aarsland TE, Bj\u00f8rkevoll M. Pantothenic acid \u2013 a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2023;67. https:\/\/doi.org\/10.29219\/fnr.v67.10255. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10770646\/. Cited 2026 Feb 24.","DOI":"10.29219\/fnr.v67.10255"},{"key":"9168_CR54","doi-asserted-by":"crossref","unstructured":"Liu C, Liu L, Ran B, Wu Y, Wang F. Linking the metals to metabolism in recurrent pregnancy loss through untargeted metabolomics and machine learning. Front Endocrinol (Lausanne). 2025;16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/41438298\/. Cited 2026 Feb 24.","DOI":"10.3389\/fendo.2025.1679190"},{"key":"9168_CR55","doi-asserted-by":"crossref","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613\u201322. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28657417\/. Cited 2026 Feb 28.","DOI":"10.1056\/NEJMoa1704559"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09168-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:45:41Z","timestamp":1781567141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09168-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9168"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09168-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the University of California, Los Angeles (UCLA) Institutional Review Board, IRB# 15\u2011001388. All participants provided written informed consent prior to enrollment. All study procedures were performed in accordance with relevant guidelines and regulations, including the principles of the Declaration of Helsinki. Study details are available at ClinicalTrials.gov (Identifier: NCT02786420).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"649"}}